News
5h
Kyodo News on MSNFinal phase of trial for Parkinson's drug to treat Alzheimer's begins in JapanThe final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...
New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...
Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...
| When clinical trial steps are managed separately, the study suffers from compounded delays. Discover proven solutions from ...
1d
News-Medical.Net on MSNAvelumab and cetuximab combination shows promise in phase II skin cancer trialA phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...
6d
Clinical Trials Arena on MSNPatient dies in Rocket’s Phase II Danon disease gene therapy trialThe FDA ordered a clinical hold on Rocket Pharmaceuticals' Danon disease trial after the adverse event was first disclosed.
3h
ScienceAlert on MSNExperimental Drug Helped Cancer Patients Live 40% Longer in Clinical TrialAn innovative new treatment for tackling some of the toughest stomach cancers has shown promise in a phase 2 clinical trial, ...
START and OneOncology launch 3 new early-phase trial sites, expanding access to new cancer research in community oncology ...
Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.
As shown in table 2, both OS and CBR values were in line or higher than those reported in the treatment arm of the ASCENT ...
Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results